CREATE MEDIC CO.,LTD.

Contact

About Create Medic

Financial Highlights

Net Sales

Net Sales by Sales Format

Ordinary Income

Net Income

Business Results Data (Cons.)

Unit:million yen

    
  FY 2018 FY 2019 FY 2020 FY 2021 FY 2022(Est.)
Net Sales 10,796 10,843 10,830 11,698 11,802

Cost of Sales
(% of Net Sales)

5,753
53.3%
5,615
51.8%
5,752
53.1%
6,438
55.0%
6,433
54.5%

Gross Profit
(% of Net Sales)

5,043
46.7%
5,228
48.2%
5,077
46.9%
5,260
45.0%
5,369
45.5%

SG&A expenses
(% of Net Sales)

4,049
37.5%
4,144
38.2%
4,092
37.8%
4,393
37.6%
4,488
38.0%

Operating Income 
(% of Net Sales)

993
9.2%
1,083
10.0%
984
9.1%
866
7.4%
881
7.5%

Ordinary Income 
(% of Net Sales)

999
9.3%
1,065
9.8%
952
8.8%
1,009
8.6%
900
7.6%

Net Income
(% of Net Sales)

672
6.2%
725
6.7%
659
6.1%
660
5.6%
638
5.4%

Net Sales by Sales Format(cons.)

Unit:million yen

  FY 2018 FY 2019 FY 2020 FY 2021 FY 2022(Est.)

Own-brand
(%)

6,558
60.7%
6,645
61.3%
6,640
61.3%
6,884
58.8%
7,000
59.3%
Overseas
(%)
2,715
25.2%
2,996
27.6%
2,943
27.2%
3,493
29.9%
3,493
29.6%
OEM Sales
(%)
1,522
14.1%
1,201
11.1%
1,245
11.5%
1,320
11.3%
1,308
11.1%
Total
(%)
10,796
100.0%
10,843
100.0%
10,830
100.0%
11,698
100.0%
11,802
100.0%

Graph Showing Financial Position

Free Cash Flow

Financial Position Data(cons.)

Unit:million yen

  
  FY 2018 FY 2019 FY 2020 FY 2021 FY 2022(Est.)

Current Assets

11,159 11,129 10,722 11,575 11,526

Fixed Assets

6,078 6,028 6,374 6,500 6,354

Total Assets
(Gross Assets)

17,237 17,157 17,097 18,075 17,880

Current Liabilities

2,914 2,651 2,583 2,573 2,581

Fixed Liabilities

1,437 1,330 1,286 1,282 1,426

Total Liabilities

4,351 3,982 3,869 3,855 4,007

Shareholders' Equity

12,886 13,175 13,227 14,220 13,873

Equity Ratio

74.8% 76.8% 77.4% 78.7% 77.6%

Cash Flow Data

Unit:million yen

  Fy 2018 FY 2019 FY 2020 FY 2021 FY 2022
(Est.)

Net cash provided by (used in) operating activities

797 880 1,249 1,248 1,302

Net cash provided by (used in) investing activities

△ 598 △ 511 △ 704 △ 585 △ 386

Net cash provided by (used in) financing activities

△ 585 △ 532 △ 845 △ 442 △ 344

Net increase in cash and cash equivalents

△ 484 △ 203 △ 343 330 571

Cash and cash equivalents at end of year

3,629 3,426 3,083 3,413 3,766

Free Cash Flow

199 368 544 663 916
  • NOTE 1) Figures are shown on a consolidated basis.
  • NOTE 2) Figures are shown rounded down to the nearest million yen.
  • NOTE 3) Free Cash Flow is represented as the total of CF from operating activities + CF from investment activities.

Investment index

  FY 2018 FY 2019 FY 2020 FY 2021 FY 2022(Est.)
ROE 5.2% 5.6% 5.0% 4.8% 4.6%
EPS(yen) 72.20 77.83 71.19 72.61 70.15
BPS(yen) 1,383.31 1,414.36 1,454.41 1,563.55 1,525.36

Dividend per Share (yen)

37 37 37 37 37

Dividend Payout Ratio(cons.)

51.2% 47.5% 52.0% 51.0% 52.7%

TOP